The largest database of trusted experimental protocols

Superscript 3

Manufactured by Thermo Fisher Scientific
Sourced in United States, Germany, United Kingdom, Japan, Australia, Canada, China, France, Spain, Netherlands, Lithuania, Switzerland, Belgium, Italy

Superscript III is a reverse transcriptase enzyme produced by Thermo Fisher Scientific. It is designed for cDNA synthesis from RNA templates during the process of reverse transcription.

Automatically generated - may contain errors

4 906 protocols using superscript 3

1

Reverse Transcription of RNA

Check if the same lab product or an alternative is used in the 5 most similar protocols
To the 5 ul of each sample, we added: 4.9 µl of RNase free water, 2.4 µl of 5x First Strand buffer (Life Technology, included with Superscript III), 1.2 µl of dNTPs (Thermo Fisher, R0193, 10 mM), 0.45 µl of 100 mM DTT (Life Technology, included with Superscript III) and 0.3 µl of dt-T7 oligo (Invitrogen, GGAGGCCGGAGAATTGTAATACGACTCACTATAGGGAGACGCGTGTTTTTTTTTTTTTTTTTTTTTTTTV, 10 ng/µl). This entire mixture was incubated for 5 minutes at 70 degrees to denature the RNA, then immediately placed on ice and the first strand enzyme mix was added: 0.3 µl of Rnasin (Promega, N2111, 2500 unit), 0.45 µl of Superscript III (Life Technology, 18080044), 1 µl of RNAse-free water. First strand synthesis was performed at 42 °C for 30 minutes, followed by 70 °C for 15 minutes.
+ Open protocol
+ Expand
2

Transcriptional Analysis of Flagellar Genes

Check if the same lab product or an alternative is used in the 5 most similar protocols
RNA isolation was carried out as described previously (38 (link)) using a RiboPure Bacteria RNA Isolation Kit (Ambion), according to the manufacturer's instructions, and treated with DNase I. To confirm cotranscription of flgN with flgK and flgL, cDNA was synthesized using the yviE gene-specific primer NSW1459 in a reaction with SuperScript III (Life Technologies) and subsequently treated with RNase H (NEB) for 20 min at 37°C. To establish if deletion of flgN perturbed transcription of flgK or flgL (and vice versa), cDNA was synthesized using random hexamers in a reaction with SuperScript III (Life Technologies). To amplify internal gene products, the following primer pairs were used: DEN5 and DEN7 (rRNA), NSW1446 and NSW1447 (flgL), NSW1444 and NSW1445 (flgK), NSW1442 and NSW1443 (flgN), and NSW1440 and NSW1441 (flgM).
+ Open protocol
+ Expand
3

Mutant Fly RNA Extraction and RT-PCR Analysis

Check if the same lab product or an alternative is used in the 5 most similar protocols
mutant stocks were made with GFP balancers. Homozygous 1st instar larval mutants (GFP-) were hand-picked under a fluorescence microscope. Animals were homogenized and RNA was extracted using the standard Trizol protocol. 2 μg of RNA was treated with Turbo DNase [Ambion] for 45 min before cDNA synthesis using SuperScript III [Life Technology] with random hexamers. rt-PCRs were done using AccuPrime™ Pfx DNA polymerase [ThermoFisher Scientific] with standard protocol using 28 cycles for mRNA and 34 cycles for intermediates.
Bx[RP] - similar to Ubx[RP] and kuz[RP], except for the following differences: homozygous mutant adult flies were homogenized and RNA was extracted using Trizol. 5 μg of RNA was DNase treated and reverse transcribed using random hexamers. rt-PCRs were done using 35 cycles for mRNA and intermediates.
Cell culture: RNA was collected from transfected cells using Trizol. 5 μg of RNA was treated with Turbo DNase [Ambion] for 45 min before cDNA synthesis using SuperScript III [Life Technology] with random hexamers. rt-PCRs were done using AccuPrime™ Pfx DNA polymerase [ThermoFisher Scientific] with standard protocol using 26 cycles and primers that were specific to minigene construct. All primers with descriptions can be found in Supplementary Table 1.
+ Open protocol
+ Expand
4

Quantification of T-cell Lineage Markers

Check if the same lab product or an alternative is used in the 5 most similar protocols
For reverse transcription, equal amounts of DNA-free RNA (500 ng) were reverse-transcribed with SuperScript III (LifeTechnologies) following the suggested conditions. Diluted cDNA was then used as input for RT-qPCR to assess MAF (Hs00193519_m1), IL4 (Hs00174122_m1), GATA3 (Hs01651755_m1), TBX21 (Hs00203436_m1), RORC (Hs01076119_m1), IL17 (Hs00174383_m1), Linc00339 (Hs04331223_m1), MALAT1 (Hs01910177_s1), RNU2.1 (Hs03023892_g1) and GAPDH (Hs02758991_g1) gene expression with Inventoried TaqMan Gene Expression assays (LifeTechnologies) were used. For assessment of linc-MAF-4 and validation of CD4+ TH1 signature lincRNAs specific primers were designed and 2.5 μg of CD4+ TH1, Treg or naive cells RNA were used for reverse transcription with SuperScript III (LifeTechnologies). RT-qPCR was performed on diluted cDNA with PowerSyberGreen (LifeTechnologies) and specificity of the amplified products was monitored by performing melting curves at the end of each amplification reaction. The primers used in qPCR are listed in Supplementary Table 2.
+ Open protocol
+ Expand
5

Quantification of T-cell Lineage Markers

Check if the same lab product or an alternative is used in the 5 most similar protocols
For reverse transcription, equal amounts of DNA-free RNA (500 ng) were reverse-transcribed with SuperScript III (LifeTechnologies) following the suggested conditions. Diluted cDNA was then used as input for RT-qPCR to assess MAF (Hs00193519_m1), IL4 (Hs00174122_m1), GATA3 (Hs01651755_m1), TBX21 (Hs00203436_m1), RORC (Hs01076119_m1), IL17 (Hs00174383_m1), Linc00339 (Hs04331223_m1), MALAT1 (Hs01910177_s1), RNU2.1 (Hs03023892_g1) and GAPDH (Hs02758991_g1) gene expression with Inventoried TaqMan Gene Expression assays (LifeTechnologies) were used. For assessment of linc-MAF-4 and validation of CD4+ TH1 signature lincRNAs specific primers were designed and 2.5 μg of CD4+ TH1, Treg or naive cells RNA were used for reverse transcription with SuperScript III (LifeTechnologies). RT-qPCR was performed on diluted cDNA with PowerSyberGreen (LifeTechnologies) and specificity of the amplified products was monitored by performing melting curves at the end of each amplification reaction. The primers used in qPCR are listed in Supplementary Table 2.
+ Open protocol
+ Expand
6

RNA Extraction, Reverse Transcription, and qPCR Analysis

Check if the same lab product or an alternative is used in the 5 most similar protocols
Total RNA was extracted using TRIzol (Life Technologies) and digested with RQ1 DNAse (M6101 Promega) following manufacturer’s instructions. For reverse transcription, 0.5 µg of RNA was heated for 5 min (min) at 65 °C and cDNA generated using SuperScript III (Life Technologies) and random primers for 1 h (h) at 50 °C, followed by heat inactivation for 15 min at 70 °C. qPCRs (for primers, see Supplemental Table S1) were performed with SYBR Green master mix (Ozyme) using a LightCycler 480 (Roche) and incubated for 2 min at 95 °C with 35 cycles of 10 s (sec) at 95 °C, 25 s at 60 °C, and 25 s at 72 °C. Data were normalized to GAPDH and analyzed using the 2−ΔΔCT method40 (link). Poly(A) tail length was analyzed using the ePAT method41 (link). Briefly, 1 µg of total RNA was incubated with 5 μM oligo-(dT)-anchor (5′GCGAGCTCCGCGGCCGCGTTTTTTTTTTTT3′) and 5 U of Klenow polymerase (New England Biolabs) for 1 h at 37 °C for template extension of the poly(A) tail, followed by reverse transcription using 200 U of SuperScript III (Life Technologies) for 1 h at 55 °C. Poly(A) tails were amplified by PCR using a gene-specific forward primer and the oligo-(dT)-anchor and migration of PCR product performed on 3% UltraPure Agarose 1000 gel (Life Technologies).
+ Open protocol
+ Expand
7

Quantitative Real-Time PCR for Protein-Coding mRNA Analysis

Check if the same lab product or an alternative is used in the 5 most similar protocols
For measuring protein-coding mRNAs, reverse transcription (RT) was performed using SuperScript III according to the manufacturer's instructions (Thermo Fisher Scientific, Waltham, MA, USA) followed by quantitative real-time PCR (RT-qPCR). For all genes, oligo-dT primer reverse transcription was performed using 350 ng of total RNA isolated from the human chondrocytes in a 20 μL RT reaction with SuperScript III, followed by qRT-PCR using 5 μL of 8-fold diluted RT reaction in 20 μL of qRT-PCR (ViiA 7 Real-Time PCR System, Thermo Fisher Scientific, Waltham, MA, USA). Transcript levels were normalized to glyceraldehyde-3-phosphate dehydrogenase (GAPDH), and the results are presented as the relative abundance using the 2–ΔΔCT method (26 (link)). The primer sequences are listed in Supplementary Table 1.
+ Open protocol
+ Expand
8

Reverse Transcription and Quantitative PCR

Check if the same lab product or an alternative is used in the 5 most similar protocols
SuperScript III (Thermo Fisher Scientific) was used to reverse transcribe 2 μg of RNA into cDNA using the random primers supplied with the SuperScript III kit. Fresh cDNA was diluted 1:10 with ddH2O and was used immediately. Primers were designed by using Primer3 (http://bioinfo.ut.ee/primer3-0.4.0/) and were selected to be located within the first half of the target gene, and to produce a product between 50 and 150 nucleotides in length. Real-time qPCR was performed with Power SYBR Green (Thermo Fisher Scientific). The Applied Biosystems ViiA 7 instrument was used with the following parameters for qPCR: (i) holding stage, 50°C for 2 min and 95°C for 10 min; (ii) PCR stage, 95°C for 15 sec and 60°C for 1 min, repeated 40 times with fluorescence recorded at 60°C; and (iii) melting curve stage, 90°C for 15 sec, 60°C for 1 min, then 95°C for 15 sec with the fluorescence recorded every 0.05 sec. Each reaction produced only one melting curve, indicating only one target was amplified during the qPCR. The threshold cycle (ΔΔCT) method was used to determine the relative amount of RNA present in the sample tested. The atpI gene was used as an internal reference to normalize the CsrA-RNA coimmunoprecipitation because we have previously shown that CsrA does not bind to the mRNA transcript of this gene (17 (link)).
+ Open protocol
+ Expand
9

Tissue Permeabilization and cDNA Synthesis

Check if the same lab product or an alternative is used in the 5 most similar protocols
Using the pre-permeabilization mix for most tissue types from the protocol, the pre-permeabilization was carried out using 0.4% Collagenase 1 (Thermo Scientific, 17018-029) in BSA (Bionordika, B9000S) and HBSS buffer (Thermo Fisher Scientific, 14025-050) and was incubated for 20 min in 37 °C. The pre-permeabilization was followed by incubation in 0.1% pepsin-HCl (Sigma-Aldrich, P7000-25G, pH 1) for 10 min at 37 °C to permeabilize the tissue. A cDNA-mix containing Superscript III (Thermo Fisher, 18080085), RNaseOUT (Thermo Fisher, 10777019), 0.1 M DTT (Thermo Fisher, included with Superscript III), dNTPs (Thermo Fisher, R0191), BSA (Bionordika, B9000S), and Actinomycin D (Sigma-Aldrich, A1410-2MG) was added and the slide incubated at 42 °C overnight (~18 h). The tissue was washed with 0.1× SSC between each incubation step.
+ Open protocol
+ Expand
10

Targeted RT-PCR Transcriptome Profiling

Check if the same lab product or an alternative is used in the 5 most similar protocols
Primers were designed to amplify at least three consecutive exons of MANE (matched annotation between NCBI and EBI) transcripts, with an RT-PCR product size between 340 to 500 bp, except for BAG3, KCNH2 and TTN, which amplified larger products due to large exon sizes. One microgram of RNA was reverse transcribed using 200 U Superscript™ III (Invitrogen, Massachusetts, United States), 4 µl Superscript III™ 5X first-strand buffer, 5 mM DTT, 40 U RNaseOUT™ (Thermo-Fisher), 0.25 mM dNTP (Roche, Basel, Switzerland) and 0.01 mM random hexamer primer (Thermo-Fisher) in a final volume of 20 µL. Complementary DNA products were diluted 1:2 in DEPC-treated water and amplified as previously described5 (link), using an annealing temperature of 60 °C unless otherwise specified (Supplementary Table 5). PCR products were resolved on an agarose gel and all gel images were derived from the same experiment. PCR products were purified using 5 U Antarctic Phosphatase (New England BioLabs, Massachusetts, United States) and 20 U Exonuclease I (New England BioLabs), and Sanger sequenced at the Macrogen Sequencing Facility (Seoul, Republic of Korea). Chromatograms were analysed using Sequencher™ v.5.4.6 (Gene Codes Corporation, Michigan, United States).
+ Open protocol
+ Expand

About PubCompare

Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.

We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.

However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.

Ready to get started?

Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required

Sign up now

Revolutionizing how scientists
search and build protocols!